For example, Zepbound has a self-pay option without insurance: $349 per month for the starting 2.5 mg dose
In the DURATION-8 study, the SGLT2i dapagliflozin was used in combination therapy with exenatide and showed reductions in HbA1c, systolic blood pressure, and blood glucose, with improved weight loss, when compared to monotherapy [93]
This article describes the weight loss efficacy of orforglipron in adults with obesity
Here's what I wish I'd understood earlier: we've been sold a lie that struggling with our bodies and brains is a character flaw
Somebody messaged me on a dating app the other day and said, Oh, you look so much better without your lips. Im like: Well, the lips are for me
Beign neoplasias and hyperplasias of melanocytes